Therapeutic strategies for optimizing PDE-5 inhibitor therapy in patients with erectile dysfunction considered difficult or challenging to treat

Simple item page
dc.contributor.authorI Sáenz de Tejada
dc.coverage.spatialBolivia
dc.date.accessioned2026-03-22T21:04:38Z
dc.date.available2026-03-22T21:04:38Z
dc.date.issued2004
dc.descriptionCitaciones: 38
dc.identifier.doi10.1038/sj.ijir.3901215
dc.identifier.urihttps://doi.org/10.1038/sj.ijir.3901215
dc.identifier.urihttps://andeanlibrary.org/handle/123456789/85789
dc.language.isoen
dc.publisherSpringer Nature
dc.relation.ispartofInternational Journal of Impotence Research
dc.sourceFundación para el Desarrollo de la Ecología
dc.subjectErectile dysfunction
dc.subjectMedicine
dc.subjectcGMP-specific phosphodiesterase type 5
dc.subjectNitric oxide
dc.subjectPhosphodiesterase
dc.subjectPharmacology
dc.subjectPhosphodiesterase inhibitor
dc.subjectEndothelial dysfunction
dc.subjectDiabetes mellitus
dc.subjectSildenafil
dc.titleTherapeutic strategies for optimizing PDE-5 inhibitor therapy in patients with erectile dysfunction considered difficult or challenging to treat
dc.typereview

Files

Collections

Artículo Científico Publicado